Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · December 14, 2024

Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer

Journal of Clinical Oncology

 

Additional Info

Journal of Clinical Oncology
Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18)
J. Clin. Oncol 2024 Nov 21;[EPub Ahead of Print], A Fagotti, B Costantini, F Fanfani, D Giannarelli, P De Iaco, V Chiantera, V Mandato, G Giorda, G Aletti, S Greggi, AM Perrone, V Salutari, R Trozzi, G Scambia

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading